 FSD Pharma Inc said it has completed its previously-announced acquisition of Canadian psychedelic pharmaceutical company Lucid Psycheceuticals Inc for about C11.3 million in FSD Pharma stock. FSD Pharma said the acquisition provides it with new assets at the forefront of new medicine and represented a paradigm shift in its development. 